永胜医疗(01612)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01612 永胜医疗

已收盘 09-14 13:40:45

0.670

+0.000

0.00%

最高0.670	最低0.650	成交量9.00万
今开0.650	昨收0.670	日振幅2.99%
总市值4.42亿	流通市值4.42亿	总股本6.60亿
成交额5.95万	换手率0.01%	流通股本6.60亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01612","market":"HK","secType":"STK","nameCN":"永胜医疗","latestPrice":0.67,"timestamp":1789364445067,"preClose":0.67,"halted":0,"volume":90000,"delay":0,"changeRate":0,"floatShares":660000000,"shares":660000000,"eps":0.1618,"marketStatus":"已收盘","change":0,"latestTime":"09-14 13:40:45","open":0.65,"high":0.67,"low":0.65,"amount":59520,"amplitude":0.029851,"askPrice":0.67,"askSize":40000,"bidPrice":0.65,"bidSize":22000,"shortable":0,"etf":0,"ttmEps":0.148366,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789435800000},"marketStatusCode":5,"adr":0,"listingDate":1468339200000,"exchange":"SEHK","adjPreClose":0.67,"dividendRate":0.068657,"openAndCloseTimeList":[[1789349400000,1789358400000],[1789362000000,1789372800000]],"volumeRatio":1.059958,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01612","defaultTab":"news","newsList":[{"id":"1168977614","title":"永胜医疗2026年中期营收4.82亿港元，净利润0.44亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1168977614","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168977614?lang=zh_cn&edition=full","pubTime":"2026-09-09 16:37","pubTimestamp":1788943072,"startTime":"0","endTime":"0","summary":"2026年上半年，永胜医疗实现营收约4.82亿港元，同比增长约7.1%。同期净利润约0.44亿港元，同比下降15.7%。公司毛利率为34.3%，较上年同期的35.4%略有下滑。本期销售及分销开支约2,207万港元，同比增加6.9%；行政开支约5,919万港元，同比增加6.2%。研发投入约2,666万港元，较上年同期增长21.7%，占营收比重增至约5.5%。报告期内经营活动现金流出现净流出约0.66亿港元，上年同期则为净流入约0.43亿港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"永胜医疗2026年中期营收4.82亿港元，净利润0.44亿港元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01612"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117817195","title":"永胜医疗8月股份月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1117817195","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117817195?lang=zh_cn&edition=full","pubTime":"2026-09-01 09:56","pubTimestamp":1788227793,"startTime":"0","endTime":"0","summary":"永胜医疗控股有限公司披露截至2026年8月31日的股份变动月报表，公告日期为2026年9月1日。报告显示，公司期内法定股本及已发行股本均未发生变化，股本结构保持稳定。公告结尾显示，公司已按照香港联合交易所有限公司的相关上市规则及法律规定进行报告，并确认截至本月末，公司公众持股量符合相关要求，股本规模整体保持不变。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01612"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129565186","title":"永胜医疗：蔡文成增持，好仓比例升至59.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=1129565186","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129565186?lang=zh_cn&edition=full","pubTime":"2026-08-27 17:11","pubTimestamp":1787821910,"startTime":"0","endTime":"0","summary":"蔡文成于2026年8月26日以每股均价0.7166港元买入永胜医疗股份100.00万股，涉资约71.66万港元。蔡文成此次增持前持有永胜医疗好仓3.93亿股，占比59.57%；增持后持股量为3.94亿股，好仓比例升至59.72%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01612"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124033822","title":"永胜医疗(01612)公布委任廖燕恩为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=1124033822","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124033822?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:04","pubTimestamp":1787648678,"startTime":"0","endTime":"0","summary":"2026年8月25日，永胜医疗控股有限公司在港交所公告，董事会已议决委任廖燕恩为公司独立非执行董事，任期自2026年8月26日起生效，为期三年，期间任何一方可提前不少于三个月书面通知终止。公告显示，廖燕恩现年54岁，拥有逾25年香港法律及金融服务行业法律、监管合规及资本市场从业经验。根据服务协议，廖燕恩将按月收取21,000港元董事酬金，薪酬以其职务及职责、公司薪酬政策及市场情况为依据。董事会对廖燕恩的加入表示欢迎。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01612"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105671695","title":"永胜医疗发布新一届董事会及五大委员会架构","url":"https://stock-news.laohu8.com/highlight/detail?id=1105671695","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105671695?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:03","pubTimestamp":1787648592,"startTime":"0","endTime":"0","summary":"2026年8月25日，永胜医疗公布自2026年8月26日起生效的新一届董事会成员及其在五大专门委员会中的职位分工。董事会共设九名成员，其中执行董事四名、非执行董事一名、独立非执行董事四名。公司指出，上述安排全部自2026年8月26日起正式生效。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01612"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662787692","title":"永胜医疗(01612.HK)：廖燕恩将获委任为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2662787692","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662787692?lang=zh_cn&edition=full","pubTime":"2026-08-25 16:55","pubTimestamp":1787648135,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01612","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144077088","title":"永胜医疗（01612）宣布截至2026年6月30日止六个月派发每股0.02港元中期股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1144077088","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144077088?lang=zh_cn&edition=full","pubTime":"2026-08-25 16:52","pubTimestamp":1787647964,"startTime":"0","endTime":"0","summary":"香港，2026年8月25日——永胜医疗控股有限公司今日发布公告称，将就截至2026年6月30日止六个月派发每股0.02港元的中期股息。永胜医疗控股有限公司董事会成员包括执行董事蔡文成、蔡章泰、许明辉及符国富；非执行董事梁明珠；独立非执行董事莫国章、区裕钊及容启亮。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01612"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662787594","title":"永胜医疗(01612)将于9月30日派发中期股息每股0.02港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662787594","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662787594?lang=zh_cn&edition=full","pubTime":"2026-08-25 16:52","pubTimestamp":1787647938,"startTime":"0","endTime":"0","summary":"智通财经APP讯，永胜医疗(01612)发布公告，将于2026年9月30日派发截至2026年6月30日止6个月的中期股息每股0.02港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485030.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","EWH","VIG","BK1100","01612","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662782025","title":"永胜医疗(01612)公布中期业绩 拥有人应占溢利达4354.8万港元 同比减少15.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662782025","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662782025?lang=zh_cn&edition=full","pubTime":"2026-08-25 16:43","pubTimestamp":1787647427,"startTime":"0","endTime":"0","summary":"智通财经APP讯，永胜医疗(01612)公布2026年中期业绩，收入按年增加7.1%至约4.82亿港元，公司拥有人应占溢利达4354.8万港元，同比减少15.65%;基本每股盈利6.71港仙，中期股息每股2.0港仙。公告称，收入增长主要受成像一次性产品分部接获更多订单量带动，足以抵销有余骨科支护复康器具分部及呼吸产品分部所出现的收入减少情况。溢利减少主要由于新生产设施的初始营运开支、系统升级及折旧，对盈利造成短期压力。然而，集团相信此等初始支出可提升长期营运效率。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485007.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"永胜医疗(01612)公布中期业绩 拥有人应占溢利达4354.8万港元 同比减少15.65%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","01612"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141052577","title":"永胜医疗（01612）2026年上半年营收4.82亿元 净利0.43亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1141052577","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141052577?lang=zh_cn&edition=full","pubTime":"2026-08-25 16:42","pubTimestamp":1787647364,"startTime":"0","endTime":"0","summary":"永胜医疗8月25日发布截至2026年6月30日止六个月未经审计中期业绩。期内，公司收入4.82亿元，同比增加7.1%。毛利1.65亿元，同比增长4.0%；毛利率34.3%，较上年同期的35.4%略有回落。期内利润方面，本公司拥有人应占溢利0.43亿元，同比下降15.7%，主要受新生产设施初始营运支出、系统升级及折旧所致。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01612"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658995109","title":"永胜医疗(01612.HK)拟8月25日举行董事会会议以批准中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2658995109","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658995109?lang=zh_cn&edition=full","pubTime":"2026-08-11 16:57","pubTimestamp":1786438622,"startTime":"0","endTime":"0","summary":"格隆汇8月11日丨永胜医疗(01612.HK)宣布，公司将于2026年8月25日(星期二)举行董事会会议，藉以(其中包括)考虑及批准公司及其附属公司截至2026年6月30日止六个月的中期业绩、刊发有关中期业绩以及派付中期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260811/32331646.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1100","01612"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132294697","title":"永胜医疗（01612）将于2026年8月25日召开董事会审议中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1132294697","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132294697?lang=zh_cn&edition=full","pubTime":"2026-08-11 16:36","pubTimestamp":1786437403,"startTime":"0","endTime":"0","summary":"永胜医疗控股有限公司（01612）8月11日公告，公司董事会已排定于2026年8月25日（星期二）召开会议，议程包括：一、审议并批准公司及其附属公司截至2026年6月30日止六个月的中期业绩；二、通过并刊发相关中期业绩公告；三、考虑派付中期股息（如有）。\n公告显示，董事会目前由八名成员组成，其中执行董事四名，非执行董事一名，独立非执行董事三名。董事会主席兼执行董事为蔡文成。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01612"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109456714","title":"永胜医疗2026年7月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1109456714","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109456714?lang=zh_cn&edition=full","pubTime":"2026-08-03 14:50","pubTimestamp":1785739842,"startTime":"0","endTime":"0","summary":"永胜医疗控股有限公司于2026年8月3日发布截至2026年7月31日的股份变动月报表。报告显示，公司整体股本结构及已发行股份数量在7月保持稳定。截至2026年7月31日，公司普通股股本总数保持不变，符合香港联合交易所有限公司相关的公众持股量要求。公司表示将继续严格遵守《香港联合交易所有限公司证券上市规则》及相关法律规定。本公告由公司秘书徐丽琪于2026年8月3日签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01612"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140701374","title":"永胜医疗更新6月股份变动月报表，股本小幅增加","url":"https://stock-news.laohu8.com/highlight/detail?id=1140701374","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1140701374?lang=zh_cn&edition=full","pubTime":"2026-07-02 12:01","pubTimestamp":1782964889,"startTime":"0","endTime":"0","summary":"永胜医疗于2026年7月2日披露了截至2026年6月30日的股份变动月报表。报告显示，公司法定注册股本维持在100,000,000港元不变，总面值为0.01港元的普通股数额仍为10,000,000,000股。新增股份主要源于股权激励计划的购股权行使，合计募集资金415,200港元；当月并无购回或注销股票动作，库存股数为零。据披露，本次公告由公司秘书徐丽琪签署。公司强调，所有已发行股份及购股权行使均遵守了监管规定，且不存在任何其他未披露的股份变动安排。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01612"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192773614","title":"永胜医疗2026年5月股份变动月报表，股本小幅增加180,000股","url":"https://stock-news.laohu8.com/highlight/detail?id=1192773614","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192773614?lang=zh_cn&edition=full","pubTime":"2026-06-02 09:35","pubTimestamp":1780364159,"startTime":"0","endTime":"0","summary":"永胜医疗控股有限公司于2026年6月2日公布了截至2026年5月31日的股份变动月报表，披露了公司在本月的股本及股份变动情况。公告显示，永胜医疗普通股法定注册资本仍为10,000,000,000股，每股面值为0.01港元，合计注册资本1亿港元。上述增发的180,000股普通股主要系公司购股权计划下的部分行使所致。截至2026年5月底，公司确认公共持股量符合香港联交所的最低要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01612"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158457511","title":"永胜医疗4月股份变动月报：已发行股本增至659,399,832股","url":"https://stock-news.laohu8.com/highlight/detail?id=1158457511","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158457511?lang=zh_cn&edition=full","pubTime":"2026-05-05 09:35","pubTimestamp":1777944940,"startTime":"0","endTime":"0","summary":"永胜医疗控股有限公司于2026年5月5日发布，截至2026年4月30日的股份变动月报。报告显示，公司法定/注册股本维持在100,000,000港元，未发生增减变动，已发行股本由上个月末的659,395,832股增至659,399,832股，增幅为4,000股。本月股本变化主要源于公司于2016年6月24日采纳并于2024年5月22日终止的购股权计划，共有4,000股期权被行使并发行为新股，同时有20,000股期权于本月内失效。截至2026年4月30日，公司股本总数较上月小幅增加，达659,399,832股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01612"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196296451","title":"永胜医疗(01612)2025年收入达9.33亿元 净利大幅提升逾五成","url":"https://stock-news.laohu8.com/highlight/detail?id=1196296451","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196296451?lang=zh_cn&edition=full","pubTime":"2026-04-23 16:37","pubTimestamp":1776933464,"startTime":"0","endTime":"0","summary":"永胜医疗于2025年年末实现综合收入9.33亿元，同比增长16.5%。期内年度溢利录得1.08亿元，上升52.8%，其中本公司拥有人应占溢利为1.04亿元，同比增长50.9%。毛利从2.60亿元升至3.27亿元，毛利率由32.5%提升至35.1%，显示盈利能力进一步增强。每股股息派息额亦由3.30港仙增加至5.00港仙，涨幅超过五成。在资产负债情况上，截至2025年12月31日，公司总资产达到11.71亿元，较上年同期增长27.4%，非流动资产约4.73亿元，流动资产约6.99亿元；权益总额6.73亿元，较2024年末增加15.4%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"永胜医疗(01612)2025年收入达9.33亿元 净利大幅提升逾五成","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01612"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186823405","title":"永胜医疗更新3月股份变动月报表，新增发行130,000股","url":"https://stock-news.laohu8.com/highlight/detail?id=1186823405","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186823405?lang=zh_cn&edition=full","pubTime":"2026-04-01 15:01","pubTimestamp":1775026880,"startTime":"0","endTime":"0","summary":"永胜医疗控股有限公司于2026年4月1日发布截至2026年3月31日的股份变动月报表。根据公告，公司于报告期内注册股本维持10,000,000,000股，总额仍为1亿港元，与上期持平。至本月末，公司确认符合香港联交所关于最低公众持股量的要求，且所有新增发行均经过董事会批准并遵循相关法律及监管规定。公司表示将继续严格遵守香港联交所《上市规则》及适用法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01612"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622026887","title":"永胜医疗(01612)发布年度业绩，股东应占溢利1.04亿港元 同比增加50.91% 末期息每股2.6港仙","url":"https://stock-news.laohu8.com/highlight/detail?id=2622026887","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2622026887?lang=zh_cn&edition=full","pubTime":"2026-03-25 16:39","pubTimestamp":1774427949,"startTime":"0","endTime":"0","summary":"智通财经APP讯，永胜医疗 发布截至2025年12月31日止年度业绩，该集团取得收入9.33亿港元，同比增加16.46%;公司拥有人应占溢利1.04亿港元，同比增加50.91%;每股基本盈利16.18港仙，拟派发末期股息每股2.6港仙。本集团的成像一次性产品分部保持势头，实现稳固的收入增长。另一方面，本集团的呼吸产品分部本年度收入表现稳定，反映需求有迹象在采购态度审慎的环境下回稳。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418698.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01612","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190125889","title":"永胜医疗2025年营收达9.328亿元 净利同比增长52.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1190125889","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190125889?lang=zh_cn&edition=full","pubTime":"2026-03-25 16:38","pubTimestamp":1774427904,"startTime":"0","endTime":"0","summary":"永胜医疗于2025年度实现收入9.328亿元，按年上升16.5%。增长主要来自成像一次性产品分部订单量的提升及其他分部的收入贡献，西班牙市场收入增幅尤其明显，由2.566亿元增长至3.685亿元，美国市场收入则从2.927亿元微升至2.981亿元。同期，呼吸产品收入为2.432亿元，健康护理及保健产品分部及其他产品收入合计1.071亿元。销售及分销开支为0.43亿元，行政开支为1.063亿元，研发开支升至0.487亿元，占总收入比重由3.8%提升至5.2%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01612"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vincentmedical.com","stockEarnings":[{"period":"1week","weight":0.0308},{"period":"1month","weight":-0.0133},{"period":"3month","weight":-0.0921},{"period":"6month","weight":-0.2887},{"period":"1year","weight":-0.3347},{"period":"ytd","weight":-0.1432}],"compareEarnings":[{"period":"1week","weight":-0.033},{"period":"1month","weight":-0.0249},{"period":"3month","weight":0.0035},{"period":"6month","weight":-0.0259},{"period":"1year","weight":-0.0491},{"period":"ytd","weight":-0.0322}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"永胜医疗控股有限公司为一家主要从事研发、制造及销售医疗器械业务的投资控股公司。该公司主要从事生产电子医疗器械、高流量氧气治疗器械、呼吸加湿系统、复康器械以及呼吸护理及麻醉相关耗材。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.038588},{"month":2,"riseRate":0.2,"avgChangeRate":-0.046634},{"month":3,"riseRate":0.3,"avgChangeRate":0.012789},{"month":4,"riseRate":0.2,"avgChangeRate":-0.010782},{"month":5,"riseRate":0.5,"avgChangeRate":-0.005347},{"month":6,"riseRate":0.4,"avgChangeRate":0.047124},{"month":7,"riseRate":0.3,"avgChangeRate":0.167132},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.035635},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.082436},{"month":10,"riseRate":0.6,"avgChangeRate":0.058179},{"month":11,"riseRate":0.4,"avgChangeRate":0.051806},{"month":12,"riseRate":0.5,"avgChangeRate":0.0139}],"exchange":"SEHK","name":"永胜医疗","nameEN":"VINCENT MED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"永胜医疗(01612)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供永胜医疗(01612)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"永胜医疗,01612,永胜医疗股票,永胜医疗股票老虎,永胜医疗股票老虎国际,永胜医疗行情,永胜医疗股票行情,永胜医疗股价,永胜医疗股市,永胜医疗股票价格,永胜医疗股票交易,永胜医疗股票购买,永胜医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"永胜医疗(01612)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供永胜医疗(01612)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}